Your support has brought us here.

Alzheimer's Association International Conference® (AAIC®) 2023 — happening now. [Alzheimer's Association]( [DONATE NOW]( [AAIC 2023]( Dear Friend, Advances in Alzheimer's disease biomarkers. Technology and dementia. New approaches to address caregiver burden and stress. These are just a few of the topics being discussed at this week's Alzheimer's Association International Conference® (AAIC®), where right at this moment, the world's leading dementia scientists are sharing breaking research discoveries that may lead to new methods of treatment and prevention. Although you may not be here in Amsterdam with us, your commitment as a member of our Alzheimer's Association community is evident in every session and workshop taking place. Along with funding care, support and cutting-edge research, [your first gift today will make events like this possible — and ensure the breakthroughs in care and research discussed here continue long after this year's AAIC ends](. [Donate Now]( Once again, AAIC is pushing the envelope and driving progress, advancing our understanding of Alzheimer's by exploring biomarkers, discovering potential ways to reduce risk and working to move promising treatments and diagnostic tools forward into clinical testing. This is a particularly promising moment for the dementia science community. There are two Food and Drug Administration (FDA)-approved treatments that signify amazing progress. These drugs go after the underlying biology of the disease process and can slow its progression in people living with early Alzheimer's. Now we must work to ensure as many people as possible who could benefit can have access to those treatments — as well as the possibility of participating in the clinical trials propelling more treatments down the pipeline — through early detection and diagnosis. Accurate diagnosis of Alzheimer's disease is complex and can be a barrier to accessing the right medications. Vital diagnostic tests, such as brain imaging, may not be readily available or covered by insurance, resulting in delays in identifying and treating the disease. The findings and discoveries that come out of AAIC this week won't be realized if people can't get an early and accurate diagnosis. With millions more Americans expected to be living with Alzheimer's in the coming years, it's extremely urgent we keep making progress. [I'm grateful that you've taken a strong interest in our work, and today I'm asking you to make your first gift to continue accelerating global research while enhancing care and support for families impacted by Alzheimer's.]( [Donate Now]( Thank you in advance for furthering our mission to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. I'm excited to think about the exchange of ideas happening this week at AAIC. As you read about new breakthroughs, there's a good chance many of them may have started with the people at this year's conference. That's not only a reflection on those researchers and scientists — it's also a reflection on you and the strength of your commitment. With appreciation, Donna McCullough Chief Mission and Field Operations Officer [Facebook]( [Twitter]( P.S. Friend, AAIC is the one time a year when the world's leading scientists and researchers assemble to share and discuss breaking research discoveries that will lead to methods of prevention and treatment, and improvements in diagnosis for Alzheimer's and all other dementias. It's also a time when your strongest possible support is urgently needed. [Thank you for your first gift today.]( Your donation will strengthen our efforts to advance Alzheimer's care, support and research. From face-to-face support to online education programs and promising global research initiatives, your gift makes a difference in the lives of all those affected by Alzheimer's and other dementias in your community and across the world. Thank you for your continued support. Alzheimer's Association Home Office, 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601 © 2023 Alzheimer's Association. All rights reserved. 800.272.3900 | [alz.org]( | [Donate]( Please add info@alz.org to your address book to ensure you receive all future emails. Having trouble reading this email? [View it in your browser]( [View your email preferences or unsubscribe](. [(